Cancer
that begins in the cervix (part of human female reproductive system) is known
as cervical cancer. The normal cells of cervix changes into abnormal cells due
to DNA mutation (mutation caused by Human Papilloma Virus, also named as HPV),
and cause this cancer. This cancer is one of the leading causes of the death
related to cancer across the world. According to analysis it is found that
about 12,500 newly cases are diagnosed and about 4,000 cases of death related
to this cancer, in 2014. More patients are cured with the help of
immunotherapy.
Cervical
cancer begins in cells on the surface of the cervix can be benign or malignant.
Benign are not a form of cancer and not as harmful as malignant (cancer).
Benign forms of this cancer are rarely a threat to life, and do not invade the
tissues around them. Malignant forms of this cancer may be a threat to life can
invade the tissues and organs around them, and can spread (metastasis) to other
parts of the body. Over time, the cervical cancer can invade more deeply into
the cervix and nearby tissues.
 |
| www.gapsos.com |
The
classification of stages of this cancer is based on where cancer cells are
found that involve stage I, stage II, stage III, and stage IV. These are the
stages of invasive cervical cancer. Stage I of this tumor has invaded only in
the cervix nearby the top layer of cells. Stage II of this tumor does not
invade to the pelvic wall and extends nearby tissues toward the pelvic wall.
Stage III of this tumor has invaded the pelvic wall extends to the lower part
of the vagina. Stage IV of this tumor invades the bladder or rectum or the
cancer has spread to other parts of the body.
Any
symptoms are seen in an early stage of this tumour is found in very rare case.
Almost symptoms are seen in advanced stages that involve abnormal vaginal
discharge including bleeding (bleeding after sex, bleeding after menopause, and
irregular menstrual cycle), pelvic pain during sex, and infections.
Cervarix
and Gardasil, both are therapeutic vaccines as well as immunotherapeutic cancer
agents, have received Food and Drug Administration (FDA) approval for the
treatment of this cancer. Both vaccines are indicated for the prevention of
this cancer, which is caused by HPV. Much more immunotherapeutic cancer agents
are under process of FDA approval for this cancer.
Global
Allied Pharmaceuticals (GAP) has technology to treat various cancers with
immunotherapy and immune combination therapy, and gives 100 percent positive
results. GAP has a team of experts for development of advanced treatments on
the basis of immunotherapeutic cancer agents.
No comments:
Post a Comment